Medical Weight Loss for Mishawaka, Indiana Residents
Mishawaka, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Mishawaka through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Mishawaka Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Mishawaka, Indiana residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Mishawaka is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Mishawaka patients at home.
Although our clinic is physically in Costa Mesa, California, Mishawaka residents receive the same physician-supervised care without leaving Indiana. We care for patients throughout downtown Mishawaka and the South Bend-Mishawaka area of St. Joseph County. Spanish-speaking Mishawaka patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Like much of Indiana, many people in Mishawaka want a physician-supervised weight-loss option without local waitlists or unclear pricing. Compounded medication arrives in discreet, cold-pack packaging at your Mishawaka address, usually within days.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Mishawaka
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Mishawaka
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Mishawaka address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Mishawaka
Does New Hope Weight Loss treat patients in Mishawaka?
Yes. Although the clinic is in Costa Mesa, California, we treat Mishawaka, Indiana residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Mishawaka?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Mishawaka address in cold-pack packaging.
What do Mishawaka patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Mishawaka do you serve?
We serve patients from across Mishawaka by telehealth, including downtown Mishawaka and the South Bend-Mishawaka area of St. Joseph County.
How does compounded medication compare on cost for Mishawaka patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Mishawaka patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Mishawaka, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.